Xuefeng S.

Xuefeng S. possesses extensive experience in quality control and analytical development within the biotechnology and pharmaceutical sectors. Currently serving as QC Senior Director at AbelZeta since September 2020, Xuefeng oversees analytical development and quality control supporting product pipelines from process development to early-phase clinical trials. Previous roles include Director of Global Process Development at WuXi AppTec, where a cross-functional team was built for cell and gene therapy products, and Chief Technology Officer at both Jiangsu Superbio Biomedical Co., Ltd. and Guangzhou IGE Biotechnology Inc., specializing in precision medicine and gene therapy. Xuefeng's earlier experience also includes significant roles in research and development, as well as academic lecturing. Xuefeng holds a PhD in Biochemistry from UT MD Anderson Cancer Center UTHealth Houston, an MS in Molecular Biology from the Chinese Academy of Sciences, and a BS in Biochemistry from Jilin University.